{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:58:41Z","timestamp":1777769921029,"version":"3.51.4"},"reference-count":32,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"unspecified","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"West Yorkshire & Harrogate Cancer Alliance","award":["PT041"],"award-info":[{"award-number":["PT041"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2026,3,20]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Survival rates from lung cancer in the UK are inferior to those experienced in other high-income countries. Improving access to investigations for people with symptoms may offer some utility to address this. This pilot investigated the potential of community pharmacy to identify and signpost people with symptoms of possible lung cancer towards an existing self-request chest X-ray service (SRCXRS) in Leeds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All community pharmacies across Leeds were invited to participate in this pilot. 27 completed necessary staff training and signposted people with symptoms of possible lung cancer towards the SRCXRS between March and September 2024. Eligibility was assessed using the existing SRCXRS criteria. Limited non-identifiable data were captured regarding the basic demographics, symptoms and medication history of people signposted. People who were signposted were provided with a unique numbered card to facilitate analysis of attendance data. Pharmacy data were used in conjunction with routinely collected attendance data from the SRCXRS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>491 people were signposted by community pharmacies (2.83\u2009patients\/pharmacy\/month). 32 people signposted attended the SRCXRS. All fulfilled the eligibility criteria to receive a chest X-ray. Nine attended with the unique number card. There was no clear evidence of difference in likelihood to attend based on Index of Multiple Deprivation (IMD) status (IMD 1\u20135=6.06%\u2009vs IMD 6\u201310=6.92%, relative risk=0.88 p=0.7) or age (p=0.42). Route to attendance data was not collected in 34.9% (n=235) of all attendees of the SRCXR during the pilot period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This pilot demonstrates that pharmacies were able to successfully identify and signpost people with symptoms of possible lung cancer. Results indicate that using community pharmacies in this capacity did not impact the likelihood of signposted patients to attend the SRCXRS based on age or IMD status. The reported outcomes are limited by a significant proportion of incomplete data regarding patients\u2019 route to attendance at the SRCXRS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-003964","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:25:34Z","timestamp":1777479934000},"page":"e003964","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Community pharmacy and lung cancer: a service innovation pilot using community pharmacy across Leeds to signpost patients with symptoms of possible lung cancers towards a patient self-request chest X-ray service"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7836-4686","authenticated-orcid":false,"given":"Andrew","family":"Walker","sequence":"first","affiliation":[{"name":"Department of Cancer Services, Leeds Teaching Hospitals NHS Trust, Leeds, UK"},{"name":"Faculty of Health and Social Care, University of Bradford School of Pharmacy, Bradford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen H","family":"Bradley","sequence":"additional","affiliation":[{"name":"The University of Sheffield School of Medicine and Population Health, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7345-6285","authenticated-orcid":false,"given":"Tom","family":"Daniels","sequence":"additional","affiliation":[{"name":"West Yorkshire Integrated Care Board, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobby S K","family":"Bhartia","sequence":"additional","affiliation":[{"name":"Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8157-0803","authenticated-orcid":false,"given":"Matthew E J","family":"Callister","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK"},{"name":"University of Leeds Leeds Institute of Health Sciences, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"2026042909251133000_13.1.e003964.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2026042909251133000_13.1.e003964.2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(10)62231-3"},{"key":"2026042909251133000_13.1.e003964.3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"The Lancet"},{"key":"2026042909251133000_13.1.e003964.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70546-1"},{"key":"2026042909251133000_13.1.e003964.5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007212","article-title":"Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey","volume":"5","author":"Rose","year":"2015","journal-title":"BMJ Open"},{"key":"2026042909251133000_13.1.e003964.6","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.542"},{"key":"2026042909251133000_13.1.e003964.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911793"},{"key":"2026042909251133000_13.1.e003964.8","unstructured":"National Institute for Clinical Excellence . Lung and pleural cancer \u2013 recognition and referral. 2021. Available: https:\/\/cks.nice.org.uk\/topics\/lung-pleural-cancers-recognition-referral\/"},{"key":"2026042909251133000_13.1.e003964.9","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp23X731985"},{"key":"2026042909251133000_13.1.e003964.10","doi-asserted-by":"crossref","unstructured":"Lung cancer stage-shift following a symptoms awareness campaign. BMJ Thorax 2018;1128\u201336. doi:10.1136\/thoraxjnl-2018-211842","DOI":"10.1136\/thoraxjnl-2018-211842"},{"key":"2026042909251133000_13.1.e003964.11","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2024.0466"},{"key":"2026042909251133000_13.1.e003964.12","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219509"},{"key":"2026042909251133000_13.1.e003964.13","unstructured":"The Leeds Teaching Hospitals NHS Trust . Radiology department. self-request chest x-ray service. n.d. Available: https:\/\/www.leedsth.nhs.uk\/services\/radiology\/self-direct-chest-x-ray-service\/"},{"key":"2026042909251133000_13.1.e003964.14","unstructured":"Department of Health. Pharmacy in England . Building on strengths \u2013 delivering the future. 2008. Available: https:\/\/assets.publishing.service.gov.uk\/media\/5a7bff2340f0b645ba3c6108\/7341.pdf"},{"key":"2026042909251133000_13.1.e003964.15","unstructured":"House of Commons Library . Future of community pharmacies. 2022. Available: https:\/\/commonslibrary.parliament.uk\/research-briefings\/cdp-2022-0113\/#:~:text=Developments%20since%20the%20NHS%20Long%20Term%20Plan&text=In%20community%20pharmacy%2C%20we%20will,reimbursement%20and%20wider%20supply%20arrangements"},{"key":"2026042909251133000_13.1.e003964.16","unstructured":"UK Parliament Health and Social Care Committee . Response to committees 12th report 2021\/22. 2022. Available: https:\/\/committees.parliament.uk\/work\/1377\/cancer-services\/publications\/"},{"key":"2026042909251133000_13.1.e003964.17","doi-asserted-by":"crossref","first-page":"102429","DOI":"10.1016\/j.canep.2023.102429","article-title":"Pre-diagnostic prescribing patterns in dyspnoea patients with as-yet-undiagnosed lung cancer: A longitudinal study of linked primary care and cancer registry data","volume":"86","author":"Wickramasinghe","year":"2023","journal-title":"Cancer Epidemiol"},{"key":"2026042909251133000_13.1.e003964.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000772"},{"key":"2026042909251133000_13.1.e003964.19","doi-asserted-by":"crossref","unstructured":"Punwani R , Nimako K , Brzezicki T , et al . Community pharmacy referrals project: increasing awareness and early diagnosis of respiratory disease via a direct pathway to secondary care. Abstract: National Cancer Research Institute; 2014. Available: https:\/\/abstracts.ncri.org.uk\/abstract\/community-pharmacy-referrals-project-increasing-awareness-and-early-diagnosis-of-respiratory-disease-via-a-direct-pathway-to-secondary-care-3\/","DOI":"10.1016\/S0169-5002(14)70084-4"},{"key":"2026042909251133000_13.1.e003964.20","unstructured":"Robinson S , Fuller E . A lung cancer health service -doncaster pharmacy direct referral for chest x-ray. ACE Programme: NHSE, CRUK, MacMillan; 2017. Available: https:\/\/www.cancerresearchuk.org\/health-professional\/diagnosis\/accelerate-coordinate-evaluate-ace-programme\/ace-programme-previous-projects#previousprojec"},{"key":"2026042909251133000_13.1.e003964.21","unstructured":"Leeds City Council . Leeds observatory. population report for leeds. 2023. Available: https:\/\/observatory.leeds.gov.uk\/"},{"key":"2026042909251133000_13.1.e003964.22","unstructured":"Walker A , Bradley SH , Bhartia BSK , et al . Community pharmacy signposting of patients with lung cancer symptoms to a self-request chest x-ray service (pilot). n.d. Available: https:\/\/osf.io\/eza5d\/"},{"key":"2026042909251133000_13.1.e003964.23","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-015-0078-3"},{"key":"2026042909251133000_13.1.e003964.24","doi-asserted-by":"crossref","unstructured":"Bradley SH , Jones D , Rafiq M , et al . Diagnosing cancer in English community pharmacies. BMJ 2024. doi:10.1136\/bmj-2023-077087","DOI":"10.1136\/bmj-2023-077087"},{"key":"2026042909251133000_13.1.e003964.25","doi-asserted-by":"crossref","unstructured":"Quaife SL , Ruparel M , Dickson JL , et al . Lung screen uptake trial (LSUT): randomized controlled clinical trial testing targeted invitation materials. Am J Respir Crit Care Med 2020;965\u201375. doi:10.1164\/rccm.201905-09460C","DOI":"10.1164\/rccm.201905-0946OC"},{"key":"2026042909251133000_13.1.e003964.26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02221-2018"},{"key":"2026042909251133000_13.1.e003964.27","doi-asserted-by":"crossref","DOI":"10.1016\/j.healthpol.2023.104951","article-title":"What impact do self-referral and direct access pathways for patients have on health inequalities?","volume":"139","author":"Harvey-Sullivan","year":"2024","journal-title":"Health Policy"},{"key":"2026042909251133000_13.1.e003964.28","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp20X713993"},{"key":"2026042909251133000_13.1.e003964.29","doi-asserted-by":"crossref","unstructured":"Clark DM , Layard R , Smithies R , et al . Improving access to psychological therapy: initial evaluation of two UK demonstration sites. Behav Res Therapy 2009;11. doi:10.1016\/j.brat.2009.07.010","DOI":"10.1016\/j.brat.2009.07.010"},{"key":"2026042909251133000_13.1.e003964.30","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.112.121855"},{"key":"2026042909251133000_13.1.e003964.31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-095540","article-title":"The Positive Pharmacy Care Law revisited: an area-level analysis of the relationship between community pharmacy distribution, urbanicity and deprivation in England","volume":"15","author":"Zied Abozied","year":"2025","journal-title":"BMJ Open"},{"key":"2026042909251133000_13.1.e003964.32","doi-asserted-by":"crossref","unstructured":"Konya J , Winder R , Dongo G , et al . Early cancer diagnosis and community pharmacies \u2013 a systematic review. Br J Gen Pract 2025. doi:10.3399\/BJGP.2025.0204","DOI":"10.3399\/BJGP.2025.0204"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-003964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:25:46Z","timestamp":1777479946000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-003964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,4,29]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/bmjresp-2025-003964"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-003964","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}